Effects of mometasone in children aged 4-9 years old with mild persistent asthma.

Trial Profile

Effects of mometasone in children aged 4-9 years old with mild persistent asthma.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 29 Nov 2011

At a glance

  • Drugs Mometasone (Primary)
  • Indications Asthma
  • Focus Pharmacodynamics
  • Most Recent Events

    • 29 Nov 2011 Primary endpoint 'Growth-rate' has been met.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top